Search research articles
Contact Us
Filters
Showing results (61-70 of 128) with videos related to
Page
of 13
Sort By:
NPJ Precision Oncology
|
May 22, 2026
Author Correction: CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages
Silvia Pietrobono, Monica Bertolini, Veronica De Vita, et al.
Oncology and Therapy
|
July 10, 2021
Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview Study
Nikunj Patel, Xandra Lie, Chad Gwaltney, et al.
International Journal of Oncology
|
December 16, 2014
Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells
Elisa Dalla Pozza, Ilaria Dando, Giulia Biondani, et al.
Biomacromolecules
|
May 24, 2024
Injectable Thermogelling Nanostructured Ink as Simultaneous Optical and Magnetic Resonance Imaging Contrast Agent for Image-Guided Surgery
Chiara Cressoni, Sarah Malandra, Emil Milan, et al.
JCO Precision Oncology
|
January 10, 2022
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
Marina Gaule, Camilla Pesoni, Alberto Quinzii, et al.
Cells
|
February 5, 2020
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer
Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, et al.
Frontiers in Surgery
|
May 23, 2022
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Valeria Merz, Domenico Mangiameli, Camilla Zecchetto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2020
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Valeria Merz, Camilla Zecchetto, Raffaela Santoro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2008
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells
Roberto Bianco, Roberta Rosa, Vincenzo Damiano, et al.
Journal of Cancer Research and Clinical Oncology
|
July 11, 2024
Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma
Valeria Merz, Francesca Maines, Stefano Marcucci, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 128) with videos related to
Sort By:
Page
of 13
NPJ Precision Oncology
|
May 22, 2026
Author Correction: CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages
Silvia Pietrobono, Monica Bertolini, Veronica De Vita, et al.
Oncology and Therapy
|
July 10, 2021
Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview Study
Nikunj Patel, Xandra Lie, Chad Gwaltney, et al.
International Journal of Oncology
|
December 16, 2014
Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells
Elisa Dalla Pozza, Ilaria Dando, Giulia Biondani, et al.
Biomacromolecules
|
May 24, 2024
Injectable Thermogelling Nanostructured Ink as Simultaneous Optical and Magnetic Resonance Imaging Contrast Agent for Image-Guided Surgery
Chiara Cressoni, Sarah Malandra, Emil Milan, et al.
JCO Precision Oncology
|
January 10, 2022
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
Marina Gaule, Camilla Pesoni, Alberto Quinzii, et al.
Cells
|
February 5, 2020
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer
Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, et al.
Frontiers in Surgery
|
May 23, 2022
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Valeria Merz, Domenico Mangiameli, Camilla Zecchetto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2020
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Valeria Merz, Camilla Zecchetto, Raffaela Santoro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2008
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells
Roberto Bianco, Roberta Rosa, Vincenzo Damiano, et al.
Journal of Cancer Research and Clinical Oncology
|
July 11, 2024
Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma
Valeria Merz, Francesca Maines, Stefano Marcucci, et al.
Page
of 13